510(k) device
Koios DS (3.8)
Koios Medical, Inc. · Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer (POK, Class II) · First FDA decision Jul 3, 2019, newest Jul 2, 2026Breast cancerCancer detection and genomic testingThyroid nodules and thyroid disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
Breakthrough-designated
Device trials
0
Naming "Koios DS"
MAUDE reports
0
Brand "Koios DS", since 2015
PubMed studies
17
Mentioning "Koios DS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Koios DS (3.8)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- Koios DS (3.8)510(k)
K253884 · Decided Jul 2, 2026 · 210 days after receipt
Device type: Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer (POK) · Radiology & Imaging
- Koios DS510(k)
K242130 · Decided Nov 15, 2024 · 116 days after receipt
Device type: Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer (POK) · Radiology & Imaging
- Koios DSBreakthrough510(k)
K212616 · Decided Dec 16, 2021 · 120 days after receipt
Device type: Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer (POK) · Radiology & Imaging
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Koios DS", any status and sponsor, newest update first.
No registered device study names "Koios DS".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Koios DS", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code POK
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Koios DS"[tiab]. The summary above synthesizes these.
- Improving the Efficacy of ACR TI-RADS Through Deep Learning-Based Descriptor Augmentation.
Barinov L, Jairaj A, Middleton WD, et al. · J Digit Imaging · 2023Research Support, Non-U.S. Gov't
- Avoidable biopsies? Validating artificial intelligence-based decision support software in indeterminate thyroid nodules.
Carnabatu CJ, Fetzer DT, Tessnow A, et al. · Surgery · 2025Validation Study
- AI: Can It Make a Difference to the Predictive Value of Ultrasound Breast Biopsy?
Browne JL, Pascual MÁ, Perez J, et al. · Diagnostics (Basel) · 2023
- Utilization of artificial intelligence to triage patients with delayed follow-up of probably benign breast ultrasound findings.
Amir T, Coffey K, Reiner JS, et al. · Ultrasonography · 2025
- Impact of an artificial intelligence decision support system among radiologists with different levels of experience in breast ultrasound: A prospective study in a tertiary center.
Irmici G, Cozzi A, Depretto C, et al. · Eur J Radiol · 2025Observational Study
- Assessment of the Diagnostic Performance of a Commercially Available Artificial Intelligence Algorithm for Risk Stratification of Thyroid Nodules on Ultrasound.
Ashton J, Morrison S, Erkanli A, et al. · Thyroid · 2024
- Application of artificial intelligence in predicting malignancy risk in breast masses on ultrasound.
Wanderley MC, Soares CMA, Morais MMM, et al. · Radiol Bras · 2023
- Should We Ignore, Follow, or Biopsy? Impact of Artificial Intelligence Decision Support on Breast Ultrasound Lesion Assessment.
Mango VL, Sun M, Wynn RT, et al. · AJR Am J Roentgenol · 2020Multicenter Study, Research Support, N.I.H., Extramural
- Artificial Intelligence in Diagnostic Breast Ultrasound: A Comparative Analysis of Decision Support Among Radiologists With Various Levels of Expertise.
Çelebi F, Tuncer O, Oral M, et al. · Eur J Breast Health · 2025
- Preliminary analysis of AI-based thyroid nodule evaluation in a non-subspecialist endocrinology setting.
Fernández Velasco P, Estévez Asensio L, Torres B, et al. · Endocrine · 2025
- Clinical Evaluation of an Artificial Intelligence-Based Decision Support System for the Diagnosis and American College of Radiology Thyroid Imaging Reporting and Data System Classification of Thyroid Nodules.
Fernández Velasco P, Pérez López P, Torres Torres B, et al. · Thyroid · 2024Research Support, Non-U.S. Gov't
- Reducing Benign Breast Biopsies in Women Aged 35 Years or Younger Using a Clinician-AI-Age Triage Strategy.
Sharma N, Baldwin J, Hendry S · Diagnostics (Basel) · 2026
Other devices of this type
Also filed under product code POK.
- Fetal EchoScan (v1.2)Brightheart · 510(k) 2025
- Sonio SuspectSonio · 510(k) 2026
- Brainomix 360 e-ASPECTSBrainomix Limited · 510(k) 2025
- Rapid ASPECTS (v3)Ischemaview, Inc. · 510(k) 2024
- BlineSlideDeep Breathe, Inc. · 510(k) 2026
- Automated Aortic Stenosis Software (AutoAS)GE Medical Systems Ultrasound & Primary Care Diagnostics, LLC · 510(k) 2026
- RevealAI-LungPrecision Medical Ventures, Inc. Dba Revealdx · 510(k) 2026
- StrokeSENS ASPECTS Software ApplicationCircle Cardiovascular Imaging, Inc. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.